Pyrroloquinoline quinone inhibits ligature-induced alveolar bone loss through regulation of redox balance and cell senescence
- PMID: 35173876
- PMCID: PMC8829629
Pyrroloquinoline quinone inhibits ligature-induced alveolar bone loss through regulation of redox balance and cell senescence
Abstract
It has been demonstrated that oxidative stress is related to periodontitis, and that pyrroloquinoline quinine (PQQ) acts as a powerful antioxidant. This study aimed to explore the effect of PQQ on ligature-induced alveolar bone loss in experimental periodontitis (EP) mice with/without PQQ in the diet. EP mice received a diet supplemented with PQQ for 2 weeks and were compared with sham (control) mice as well as untreated EP mice. Additionally, human periodontal ligament cells (hPDLCs) were treated with PQQ in the presence or absence of lipopolysaccharide (LPS). We found that the bone volume fraction, alkaline phosphatase activity, and the number of antioxidant cells were significantly decreased in EP mice compared with the sham mice, whereas PQQ administration rescued the above effects. In contrast, alveolar bone loss, osteoclast number, cell senescence-associated cells, and cytokines' expression were significantly increased in EP mice compared with the sham mice but were significantly decreased with PQQ supplementation in periodontal tissues. Furthermore, we found that antioxidant enzymes and Bmi-1 protein expression levels were downregulated, whereas the protein expression levels of cell senescence-related proteins including γ-H2AX, IL-6, IL-1β, p16, and p21 were significantly up-regulated in LPS-induced hPDLCs compared with the control cells. However, PQQ administration partially prevented these changes. These findings suggest that PQQ may alleviate periodontal damage through regulation of the redox balance and cell senescence.
Keywords: Pyrroloquinoline quinone; alveolar bone resorption; inflammation; oxidative stress; periodontitis.
AJTR Copyright © 2022.
Conflict of interest statement
None.
Figures
Similar articles
-
Pyrroloquinoline quinone prevents knee osteoarthritis by inhibiting oxidative stress and chondrocyte senescence.Am J Transl Res. 2019 Mar 15;11(3):1460-1472. eCollection 2019. Am J Transl Res. 2019. PMID: 30972174 Free PMC article.
-
Pyrroloquinoline quinone prevents testosterone deficiency-induced osteoporosis by stimulating osteoblastic bone formation and inhibiting osteoclastic bone resorption.Am J Transl Res. 2017 Mar 15;9(3):1230-1242. eCollection 2017. Am J Transl Res. 2017. PMID: 28386349 Free PMC article.
-
Pyrroloquinoline quinone plays an important role in rescuing Bmi-1-/- mice induced developmental disorders of teeth and mandible--anti-oxidant effect of pyrroloquinoline quinone.Am J Transl Res. 2018 Jan 15;10(1):40-53. eCollection 2018. Am J Transl Res. 2018. PMID: 29422992 Free PMC article.
-
Pyrroloquinoline-quinone to reduce fat accumulation and ameliorate obesity progression.Front Mol Biosci. 2023 May 5;10:1200025. doi: 10.3389/fmolb.2023.1200025. eCollection 2023. Front Mol Biosci. 2023. PMID: 37214340 Free PMC article. Review.
-
Pyrroloquinoline-quinone and its versatile roles in biological processes.J Biosci. 2012 Jun;37(2):313-25. doi: 10.1007/s12038-012-9195-5. J Biosci. 2012. PMID: 22581337 Review.
References
LinkOut - more resources
Full Text Sources